Importance of race/ethnicity in clinical trials: Lessons from the African-American Heart Failure Trial (A-HeFT), the African-American Study of Kidney Disease and Hypertension (AASK), and the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

Authors

Anne L. Taylor, University of Minnesota Medical School
Jackson T. Wright, Case Western Reserve University
Richard S. Cooper, Stritch School of Medicine

Document Type

Article

Publication Date

12-1-2005

Publication Source (Journal or Book title)

Circulation

First Page

3654

Last Page

3660

Recommended Citation

Taylor, A., Wright, J., & Cooper, R. (2005). Importance of race/ethnicity in clinical trials: Lessons from the African-American Heart Failure Trial (A-HeFT), the African-American Study of Kidney Disease and Hypertension (AASK), and the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Circulation, 112 (23), 3654-3660. https://doi.org/10.1161/CIRCULATIONAHA.105.540443